Inovio Pharmaceuticals Inc (NASDAQ: INO) stock closed at $11.04 on 7/11/24 after a major increase of 19.0%. Moreover, this advance was accompanied by exceptionally high trading volume at 222% of normal. The stock has risen 31.0% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
INO’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Inovio Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Inovio Pharmaceuticals has a very low Appreciation Score of 10 but a very high Power Rating of 88, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment